Position in ZVRA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,925,914
+$1,651,163 QoQ
Shares Held
743,124
+26.2% QoQ
Ownership
1.26%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 99.94213617108316.ToString("F0")%
Shared 0.ToString("F0")%
None 0.05786382891684295.ToString("F0")%
Common Shares in ZVRA Over Time
Shares Held
Position Value (USD)
Derivatives in ZVRA
reported options exposure · as of Mar 31, 2026CallValue
$219,952
CallShares
23,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. ZVRA ranks #160 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in ZVRA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,925,914 | 743,124 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $219,952 | 23,600 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $5,274,751 | 588,700 | Shares | Defined | 2026-03-25 | |
| 2025-12-31 | $211,456 | 23,600 | Call | Defined | 2026-03-25 | |
| 2025-09-30 | $7,244,498 | 761,777 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,301,916 | 374,792 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,459,149 | 194,813 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $2,084,457 | 249,935 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $873,294 | 125,835 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $168,951 | 34,480 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $116,145 | 20,025 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $233,854 | 35,703 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $146,363 | 30,366 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $186,777 | 36,623 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $180,570 | 32,831 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $107,057 | 23,324 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $164,817 | 26,413 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $344,044 | 77,140 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $765,354 | 152,158 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,661,780 | 190,790 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $1,573,867 | 168,689 | Shares | Defined | 2022-01-20 | |
| 2021-03-31 | $311,944 | 33,907 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||